Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

Peer Review reports

Original Submission
27 Apr 2018	Submitted	Original manuscript
3 Nov 2018	Reviewed	Reviewer Report - Felipe Castañeda
4 Nov 2018	Reviewed	Reviewer Report - Maria Ciarleglio
10 Dec 2018	Author responded	Author comments - James W Dear
Resubmission - Version 2
10 Dec 2018	Submitted	Manuscript version 2
12 Dec 2018	Reviewed	Reviewer Report - Felipe Castañeda
12 Dec 2018	Reviewed	Reviewer Report - Maria Ciarleglio
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
13 Dec 2018	Editorially accepted
8 Jan 2019	Article published	10.1186/s13063-018-3134-1

Back to article page